submission_id,submission_title,manufacturer,country,region,stage_of_development,target_pathogen,permalink,regulatory_status,other_regulatory_status,planned_market_entry,primary_use_case,type_of_technology,technology_principle,assay_aim,assay_target,target_analyte,disease_target_phase,readout_technology,resistance_marker,test_format,other_test_format,instrument_requirement,level_of_automation,lab_vs_poc,self_testing_self_collection,validated_sample_types,other_validated_sample_type,time_to_results_excl_prep,test_to_be_listed_on_finds_web_page,data_to_be_published_on_finds_web_page,target_patient_group,type_data_source,study_type,drug_resistance_target,other_drug_resistance_target,sensitivity,sensitivity_ci_low,sensitivity_ci_up,specificity,specificity_ci_low,specificity_ci_up,total_number_samples,sample_type,number_positive_samples,number_negative_samples
a2r69000007lbFN,Diagnostic Kit for Mycobacterium Tuberculosis (TB) DNA,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://en.bioustar.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Isothermal NAT(other),ID,DNA,Unknown,NA,Unspecified,Not applicable,Cartridge-based processing,NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,42,31,55,91,85,95,3449,Urine,1277,2172
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,35,22,50,95,89,98,3365,Urine,432,2933
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,52,40,64,87,78,93,2253,Urine,868,1385
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,29,17,47,96,91,99,1196,Urine,409,787
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,62,41,83,84,48,96,537,Urine,159,378
a2r69000007lbEm,Determine TB-LAM Ag,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,25,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,31,18,47,95,87,99,2828,Urine,273,2555
a2r69000007lb91,IP-10 IGRA LF,R-Biopharm AG,Germany,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://r-biopharm.com,None,NA,Unknown,Triage/Screening,Immunoassay,IGRA,ID,Antigen,Interferon Gamma,Latent,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFH,IP-10 IGRA ELISA,R-Biopharm AG,Germany,European Region,Research Use Only (RUO),Mycobacterium Tuberculosis,https://r-biopharm.com,None,NA,Unknown,Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,Latent,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,heprin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFL,STANDARD E TB-Feron ELISA,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://sdbiosensor.com,CE-IVDD; Korea MFDS,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,Latent,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Plasma,NA,100,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEo,INFINITIMTB Assay,Autogenomics,United States,Region of the Americas,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://autogenomics.com/?q=node/42,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,katG; pncA; rpoB,Cartridge-based processing,microarray chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF6,MDR/XDR multi-test kit,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://bioneer.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,Unknown,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,60,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,99.7,98.4,99.9,98.5,91.9,99.7,417,Sputum,351,66
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,76.1,67.6,82.9,98.8,97.5,99.4,679,Sputum,117,562
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,85,82,88,98,97,98,37237,Sputum,0,0
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,98,97,98,0,0,0,18275,Sputum,0,0
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,67,62,72,98,98,99,18962,Sputum,0,0
a2r69000007lb94,Xpert MTB/RIF,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; US FDA 510k; WHO recommended; Other,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB rpoB gene,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,96,94,97,98,98,99,8020,Sputum,0,0
a2r69000007lb95,Xpert MTB/RIF Ultra,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,60,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Isoniazid,NA,95.2,92.9,96.8,95.6,90.1,98.1,596,Sputum,464,132
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Fluoroquinolone,NA,94.5,90.7,96.9,95.2,92.5,96.9,594,Sputum,226,368
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Amikacin,NA,87.7,77.5,93.6,98.5,97,99.2,593,Sputum,65,528
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Kanamycin,NA,93.7,89,96.4,92.4,89.4,94.6,594,Sputum,195,399
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Capreomycin,NA,75.4,64,84,99.6,98.6,99.9,595,Sputum,54,541
a2r69000007lb96,Xpert MTB/XDR,Cepheid,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://cepheid.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended; Israel Ministry of Health,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,eis promoter; fabG1; gyrA; gyrB; inhA promoter; katG; Other; oxyR-ahpC intergenic region; rrs,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,90,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Ethionamide,NA,55,49.5,60.3,93.8,90.3,96.1,597,Sputum,194,403
a2r69000007lbFE,T-SPOT.TB,Oxford Immunotec Limited,United Kingdom,European Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://oxfordimmunotec.com,CE-IVDD; WHO recommended,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,MTB CFP-10; MTB ESAT-6,Latent,Colorimetric,Not applicable,Unspecified,NA,A proprietary/new instrument is optional,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLJ,Abbott RealTime MTB,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS6110; MTB pab gene,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6C,Abbott RealTIme MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Rifampicin,NA,94.8,88.3,98.3,100,97,100,216,Sputum,91,125
a2r69000007lb6C,Abbott RealTIme MTB RIF/INH,Abbott Molecular,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://abbottmolecular.com/home.html,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,NALC treated sputum and bronchialalveolar lavages,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Isoniazid,NA,88.3,80,94,94.3,88.6,97.7,217,Sputum,90,127
a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://moleculardiagnostics.bd.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,94.5,91.7,96.4,94.9,91.1,97.1,596,Sputum,371,225
a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://moleculardiagnostics.bd.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Rifampicin,NA,100,87.1,100,100,98.2,100,232,Sputum,26,206
a2r69000007lbEr,BD MAX MDR-TB,BD Molecular Diagnostics,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://moleculardiagnostics.bd.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Other,Sputum Sediment,240,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Isoniazid,NA,100,91.8,100,100,98.1,100,242,Sputum,43,199
a2r69000007lbEs,AccuPower TB&MDR RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Fluorescence,fabG1; inhA; katG; oxyR-ahpC intergenic region; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF4,AccuPower XDR-TB RealTime PCR kit-A,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Fluorescence,gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF5,AccuPower XDR-TB RealTime PCR kit-B,Bioneer Corporation,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://bioneer.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Fluorescence,embB; rpsL,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Bronchoalveolar lavage; Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFM,C-Tb skin test,Serum Institute of India,India,South-East Asian Region,Research Use Only (RUO),Mycobacterium Tuberculosis,https://seruminstitute.com,Unknown,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Host Immune Response,ID,Antigen,MTB CFP-10; MTB ESAT-6,Latent,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLA,TB LAM assay,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://sdbiosensor.com,None,NA,Unknown,Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFJ,FLOW TB,Salus Discovery,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://salusd.com globalaccessdx.com,None,NA,Unknown,Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000006Skdn,Wantai TB-IGRA,"Beijing Wantai Biological Pharmacy Enterprise Co., Ltd",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://ystwt.cn,China NMPA; WHO recommended,NA,NA,Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,Latent,Colorimetric,Not applicable,IA Reagent Kit,NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,NA,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLH,NOVA Test Tuberculosis IGG/IGM Tri-line Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis,https://atlas-link.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antibody (serological),MTB IgG; MTB IgM,NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Plasma; Serum; Whole Blood,NA,15,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLI,NOVA Test Tuberculosis Antibody Test,"Atlas Link Technology Co., Ltd.",China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis,https://atlas-link.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antibody (serological),Unknown,NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Serum,NA,15,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLK,Recombinant mycobacterium tuberculosis fusion protein(EC)n,Anhui Zhifei Longcom Biopharmaceutical Co. Ltd.,China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://zflongkema.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Host Immune Response,ID,Antigen,PPD tuberculin,NA,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLL,IRISA-TB,Antrum Biotech,South Africa,African Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://antrumbiotech.co,None,NA,Unknown,Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,Latent,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Cerebrospinal fluid (CSF); Other,Pleural fluid; Pericardial fluid; Peritoneal fluid;,120,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6F,MeltPro MTB/RIF Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,rpoB,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6B,MeltPro MTB/SL Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,eis promoter; rrs,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6H,MeltPro MTB/INH Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA; inhA promoter; oxyR-ahpC intergenic region,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6G,MeltPro MTB/STR Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,rpsL,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6J,MeltPro MTB/FQ Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,gyrA,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6I,MeltPro MTB/EMB Test Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,CE-IVDD; Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,embB,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFP,MeltPro Mycobacteria Identification Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://zeesandx.com,CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB ITS,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFO,MeltPro TB Assay,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,Other,China CDFA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS6110,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFQ,MeltPro Mycobacterium Tuberculosis McSpoligotyping Kit,"Xiamen Zeesan Biotech Co., ltd.",China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://zeesandx.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,Other,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8t,T-Track TB part 2 - T-Track TB Quant PCR,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://mikrogen.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Molecular,qPCR,ID,RNA,Interferon Gamma; Other,Latent,Fluorescence,Not applicable,NAT reagent kit (open source),NA,A proprietary/new instrument is optional,Manual,Lab-based,Intended for professional use only,Purified RNA,NA,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8w,TB22 signature in-house assay,Research Center Borstel,Germany,European Region,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://fz-borstel.de/index.php/en,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,qPCR,Host Response,RNA,Unknown,NA,Fluorescence,Not applicable,Unspecified,NA,Unknown,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8z,RISK 6 host response assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://quantumdx.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,qPCR,Host Response,RNA,Unknown,NA,Fluorescence,Not applicable,Unspecified,NA,Unknown,Unknown,Lab-based,Intended for professional use only,Finger prick blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLD,Single-Molecule Immunoassay for Triaging Tuberculosis,Wyss Institute,United States,Region of the Americas,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://wyss.harvard.edu,Unknown,NA,Unknown,Triage/Screening,Immunoassay,Unspecified,ID,Antigen,Lipoarabinomannan (LAM); Other,NA,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEy,T-Track TB part 1 - T-Track TB Stimulation,Mikrogen GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://mikrogen.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Other,ID,Antigen,MTB CFP-10; MTB ESAT-6,NA,Fluorescence,Not applicable,Other,Stimulation/incubation,A proprietary/new instrument is optional,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,1440,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbL8,RidTB,GenEndeavor llc,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://Genendeavor.com,None,NA,Unknown,Triage/Screening,Molecular,Other,ID,DNA,MTB IS6110,NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8p,Erythra-TB-KIT,Erythra Inc.,China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis,http://www.genenexus.com/,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Other,NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Other,Heamolysate,5,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFB,floDx miniMDR-TB,EMPE Diagnostics,India,South-East Asian Region,Regulatory Status Unknown,Mycobacterium Tuberculosis,https://empediagnostics.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Other,ID-Prediction AST,DNA,MTB ITS,NA,Colorimetric,inhA; katG; rpoB,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8o,floDx pre-XDR-TB,EMPE Diagnostics,India,South-East Asian Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://empediagnostics.com,None,NA,2023,Diagnostic/confirmatory test,Molecular,Other,ID-Prediction AST,DNA,MTB ITS,NA,Colorimetric,gyrA; inhA; katG; rpoB,Rapid diagnostic test (strip or cassette),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8j,LoopampTM MTBC Detection Kit,"Eiken Chemical Co., Ltd.",Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://eiken.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Isothermal LAMP,ID,DNA,MTB gyrB Gene; Other,NA,Fluorescence,Not applicable,NAT reagent kit (open source),NA,Standard lab instrumentation is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,40,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF8,Nucleic Acid Identification Tool (NABIT),Conservation X Labs,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://conservationxlabs.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB 23S rRNA; MTB IS6110; MTB rpoB gene; MTB sdaA gene,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Oropharyngeal swab,NA,90,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEz,Mylab PathoDetect MTB Detection kit,Mylab Discovery Solutions Pvt ltd.,India,South-East Asian Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://mylabdiscoverysolutions.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS6110,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Sputum; Sputum Culture; Other,EPTB specimen,80,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF0,Mylab PathoDetect MTB RIF and INH resistance detection kit,Mylab Discovery Solutions Pvt ltd.,India,South-East Asian Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://mylabdiscoverysolutions.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Fluorescence,Unknown,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Unknown,near Point of Care,Intended for professional use only,Sputum; Sputum Culture; Other,EPTB specimen,80,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb68,Truenat MTB-BDQ,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Not applicable,NA,Fluorescence,atpE,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb67,Truenat MTB-FQ,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Not applicable,NA,Fluorescence,gyrA,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbL5,T cell activation marker (TAM-TB) assay,Beckman Coulter Inc.,United States,Region of the Americas,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://beckmancoulter.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Immunoassay,Flow Cytometry,ID,Antigen,Other,NA,Fluorescence,Not applicable,Other,Flow cytometry,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbL9,PATHFAST-LAM,LSI Medience Corporation,Japan,Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://www.medience.co.jp/english/,None,NA,Unknown,"Triage/Screening; Monitoring (treatment, immune status, patient)",Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLE,gLAMexpress,Mologic ltd.,United Kingdom,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://mologic.co.uk,None,NA,Unknown,Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Lipoarabinomannan (LAM),NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Urine,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEn,TruArray MDR-TB,"Akonni Biosystems, Inc.",United States,Region of the Americas,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://akonni.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB IS1245; MTB IS6110,NA,Colorimetric,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbTQ,ichroma CRP,Boditech Med.,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://boditech.co.kr/en,Health Canada; India CDSCO; US FDA 510k,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay,Not applicable,Antigen,C-reactive protein,NA,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma; Serum; Whole Blood,NA,3,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb6D,Truenat MTB-RIF,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://molbiodiagnostics.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,rpoB,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Rifampicin,NA,84.2,62.4,94.5,95.2,90.8,97.5,0,Sputum,0,0
a2r69000007lb6D,Truenat MTB-RIF,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://molbiodiagnostics.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,rpoB,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,81.6,66.6,90.8,97.8,94.4,99.1,218,Sputum,35,183
a2r69000007lb8k,Truenat MTB,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://molbiodiagnostics.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB nrdB gene,NA,Fluorescence,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,91.1,0,0,100,0,0,226,Sputum,191,35
a2r69000007lb6E,Truenat MTB-INH,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://molbiodiagnostics.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA; katG,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Isoniazid,NA,100,0,0,96.15,0,0,50,Sputum,0,0
a2r69000007lb8l,Truenat MTB plus,Molbio Diagnostics Pvt Ltd,India,South-East Asian Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://molbiodiagnostics.com,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS6110; MTB nrdz gene,NA,Fluorescence,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Purified DNA,Sputum or EPTB specimen,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,79.8,74.5,84.3,96.5,95.2,97.4,1654,Sputum,0,0
a2r69000007lbF9,MDR/MTB ELITe InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Fluorescence,inhA; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFA,MTB EXTRA ELITe InGenius platform,ELITechGroup,France,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://elitechgroup.com,Brazil ANVISA; CE-IVDD,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS6110,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Urine; Other,Cavitary Fluid; Biopsies/Tissue Bronchial Aspirate (BA); Gastric Aspirates,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Pyrazinamide,NA,81.2,75.4,85.8,97.8,96.5,98.6,0,Urine,0,0
a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Pyrazinamide,NA,96.4,93.3,98.4,100,99.4,100,0,Urine,0,0
a2r69000007lb69,Genoscholar PZA-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Colorimetric,pncA,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Pyrazinamide,NA,95.7,93.5,97.2,98.6,97.4,99.2,0,Urine,0,0
a2r69000007lbll,Genoscholar FQ+KM-TB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Status Unknown,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,Unknown,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,Prediction AST,DNA,Not applicable,NA,Colorimetric,gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,0,75,100,0,96.5,100,0,Urine,0,0
a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,0,50,94.9,0,96.5,97.8,0,Urine,0,0
a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,0,92.8,98.9,0,97.3,98.2,0,Urine,0,0
a2r69000007lbFD,Genoscholar NTM+MDRTB II,Nipro Corporation,Japan,Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://nipro.co.jp,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Other,Culture,1440,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,0,61.6,91.6,0,99.4,100,0,Urine,0,0
a2r69000007lb6A,Roche cobas MTB-RIF/INH,Roche Diagnostics International Ltd.,Switzerland,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Rifampicin,NA,96.7,91.7,99.1,97.9,95.8,99.2,0,Sputum,0,0
a2r69000007lb6A,Roche cobas MTB-RIF/INH,Roche Diagnostics International Ltd.,Switzerland,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Not applicable,NA,Fluorescence,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Isoniazid,NA,97.4,93.5,99.3,99.3,97.6,99.9,0,Sputum,0,0
a2r69000007lb8y,Diagnostic Kit for Mycobacterium Tuberculosis Complex DNA,Ustar Biotechnologies (Hangzhou) Ltd.,China,Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://en.bioustar.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Isothermal NAT(other),ID,DNA,Unknown,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Sputum,NA,80,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb93,ichroma IGRA-TB 25,Boditech Med Inc.,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://www.boditech.co.kr,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay; IGRA,ID,Antigen,Interferon Gamma,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Plasma,Li-Heprin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFK,STANDARD M MDR-TB,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Research Use Only (RUO),Mycobacterium Tuberculosis,https://sdbiosensor.com,None,NA,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,inhA; katG; rpoB,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,30,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLC,STANDARD F TB-Feron FIA,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://sdbiosensor.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Interferon Gamma,NA,Fluorescence,Not applicable,Rapid diagnostic test (strip or cassette),NA,A proprietary/new instrument is required,Manual,near Point of Care,Intended for professional use only,Plasma,sensitized whole blood in TB-Feron Tubes,15,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLB,STANDARD M MTB/NTM,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://sdbiosensor.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB IS1081; MTB IS6110,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF2,Gendrive MTB/RIF ID,Epistem Limited,United Kingdom,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://epistem.co.uk,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,Unknown,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8x,STANDARD M XDR-TB,SD BIOSENSOR INC,"Korea, Republic of",Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://sdbiosensor.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,Unknown,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbL6,VIDAS TB-IGRA,bioMérieux,France,European Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://biomerieux-diagnostics.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,Latent,Fluorescence,Not applicable,Other,Reagent strip,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,1020,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbL7,ISIT-TB,bioMérieux,France,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://biomerieux-diagnostics.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,qPCR,Host Response,RNA,Other,Latent,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Whole Blood,NA,60,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFC,Nanodisk-MS2,NanoPin,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://ceigateway.com/client-profiles/nanopin-technologies,None,NA,Unknown,Triage/Screening,Immunoassay,Other,ID,Antigen,MTB CFP-10,NA,Unspecified,Not applicable,Unspecified,NA,Standard lab instrumentation is required,Unknown,Lab-based,Intended for professional use only,Serum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbAY,LumiraDx MTB qSTAR Test,LumiraDx,United Kingdom,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://lumiradx.com/us-en/what-we-do/diagnostics/fast-lab-solutions,None,NA,2023,Triage/Screening,Molecular,qPCR,ID,DNA,Unknown,NA,Electrochemical,Not applicable,Cartridge-based processing,chip based,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Other,tongue,15,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLG,Simoa SR-X,Quanterix,United States,Region of the Americas,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://quanterix.com,Unknown,NA,Unknown,Triage/Screening,Immunoassay,Other,ID,Antigen,Other,NA,Fluorescence,Not applicable,Unspecified,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb97,Xpert MTB Host Response assay,Cepheid,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://cepheid.com,None,NA,Unknown,"Monitoring (treatment, immune status, patient)",Molecular,qPCR,Host Response,RNA,MTB DUSP3; MTB GBP5; MTB KLF2,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFF,QuantiFERON-TB Gold Plus (QFT-Plus),QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://www.qiagen.com,CE-IVDD; US FDA PMA; WHO recommended,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,NA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8u,MARTI point-of-care TB diagnostic test,MARTI TB Diagnostics (Pty) Ltd,South Africa,African Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://martidiagnostic.com,None,NA,Unknown,Triage/Screening,Immunoassay,Other,ID,Antibody (serological),Unknown,NA,Electrochemical,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb90,Q-POC - TB Assay,QuantuMDx Group Limited,United Kingdom,European Region,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://quantumdx.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,Unknown,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Unknown,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Other,Independent,Not applicable,NA,0,0,0,0,0,0,0,Sputum,0,0
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Other,Independent,Fluoroquinolone,NA,0,0,0,0,0,0,0,Sputum,0,0
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Other,Independent,Other,SLID resistance,0,0,0,0,0,0,0,Sputum,0,0
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,98.8,0,0,89.6,0,0,331,Sputum,259,72
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Fluoroquinolone,NA,93.1,0,0,100,0,0,251,Sputum,54,197
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Amikacin,NA,94.7,0,0,98.1,0,0,251,Sputum,40,211
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Capreomycin,NA,90,0,0,98.1,0,0,251,Sputum,40,211
a2r69000007lb8n,GenoType MTBDRsl version 2,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,eis promoter; gyrA; gyrB; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture,Sputum Culture isolates,300,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Kanamycin,NA,94.8,0,0,96.6,0,0,251,Sputum,79,172
a2r69000007lb8q,FluoroType XDR VER 1.0,Hain Lifescience GmbH,Germany,European Region,Research Use Only (RUO),Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Unknown,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,embB; gyrA; gyrB; rplC; rrl; rrs,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEq,Blood based active TB test,BD Biosciences,United States,Region of the Americas,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://bdbiosciences.com/en-us,None,NA,Unknown,Triage/Screening,Immunoassay,Flow Cytometry,ID,Antigen,Unknown,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,30,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFG,LIAISON QuantiFERON-TB Gold Plus assay,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://www.qiagen.com,CE-IVDD; US FDA PMA,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,MTB CFP-10; MTB ESAT-6,NA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Whole Blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbLF,QIAReach QuantiFERON-TB,QIAGEN GmbH,United States,Region of the Americas,Regulatory Achieved,Mycobacterium Tuberculosis,https://www.qiagen.com,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Lateral Flow Assay; IGRA,ID,Antigen,Interferon Gamma,NA,Fluorescence,Not applicable,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Whole Blood,NA,1440,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbFI,Roche cobas MTB,Roche Diagnostics International Ltd.,Switzerland,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://molecular.roche.com,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID,DNA,MTB 23S rRNA; Other,NA,Fluorescence,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Bronchoalveolar lavage; Sputum; Other,Sputum Sediment,NA,Yes,Yes,Active TB,Instructions for Use (IFU),Company-Sponsored,Not applicable,NA,98.9,96.9,99.7,98.2,96.1,99.3,0,Sputum,0,0
a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,96.8,94.7,98.1,98.1,96.9,98.8,0,Sputum,0,0
a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,88.4,84.4,91.6,98.3,97.4,98.9,0,Sputum,0,0
a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,97.3,95.7,98.3,99.5,98.8,98.8,0,Sputum,0,0
a2r69000007lc4c,GenoType MTBDRplus VER 1.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,91.5,89,93.5,99.8,99.3,100,0,Sputum,0,0
a2r69000007lbEu,FluoroType MTBDR VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,95.8,92.6,97.6,98.4,96.9,99.2,0,Sputum,0,0
a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,94.5,91.4,96.5,99.3,92.6,100,0,Sputum,0,0
a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Rifampicin,NA,91.3,0,0,98,0,0,0,Sputum,0,0
a2r69000007lbEv,GenoType MTBDRplus VER 2.0,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,Brazil ANVISA; CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,Hybridization,ID-Prediction AST,DNA,MTB 23S rRNA,NA,Colorimetric,inhA promoter; katG; rpoB,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Manual,Lab-based,Intended for professional use only,Sputum; Sputum Culture; Other,bronchial material; Aspirates,300,Yes,Yes,Active TB,Other,Independent,Isoniazid,NA,89.4,0,0,98.9,0,0,0,Sputum,0,0
a2r69000007lbF1,FluoroType Mycobacteria VER 1.0 PCR Kit,Hain Lifescience GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis; Mycobacterium Tuberculosis Complex Species,https://hain-lifescience.de/en/,CE-IVDD; WHO recommended,WHO recommended,Already on the market (commercialized),Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB IS6110,NA,Colorimetric,Not applicable,NAT reagent kit (proprietary platform),NA,A proprietary/new instrument is required,Automated (excluding sample preparation),Lab-based,Intended for professional use only,Sputum; Sputum Culture,liquid Sputum Culture from Mgit,180,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF3,Diaskintest,Generium,Russian Federation,European Region,Regulatory Status Unknown,Mycobacterium Tuberculosis,https://generium.ru/en,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,Host Immune Response,ID,Antigen,MTB CFP-10; MTB ESAT-6,Latent,Colorimetric,Not applicable,Other,Injectable,No instrumentation is required,Manual,True Point of Care,Intended for professional use only,Other,injection under skin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEw,TB Triage multiplex LFA,Leiden Unversity Medical Center,Netherlands,European Region,Early Stage Development (partial prototype),Mycobacterium Tuberculosis,https://lumc.nl,None,NA,Unknown,Triage/Screening,Immunoassay,Lateral Flow Assay,ID,Antigen,Unknown,NA,Colorimetric,Not applicable,Rapid diagnostic test (strip or cassette),NA,No instrumentation is required,Manual,near Point of Care,Intended for professional use only,Finger prick blood,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEx,LIOFeron TB/LTBI IGRA; HUMAN IFN-g ELISA KIT,LIONEX Diagnostics & Therapeutics GmbH,Germany,European Region,Regulatory Achieved,Mycobacterium Tuberculosis,https://lionex.de,CE-IVDD,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,NA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,Blood stimulation tubes,1440,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8v,AdvanSure TB-IGRA ELISA,LG Chem Life Sciences Company,United States,Region of the Americas,Research Use Only (RUO),Mycobacterium Tuberculosis,https://innovation.lgchem.com,None,NA,Already on the market (commercialized),Triage/Screening,Immunoassay,ELISA/EIA; IGRA,ID,Antigen,Interferon Gamma,NA,Colorimetric,Not applicable,Chemiluminescent Immunoassay (CLIA),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Whole Blood,heprin,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lb8s,TB-MBLA,Life Arc,United Kingdom,European Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://lifearc.org,None,NA,2023,"Monitoring (treatment, immune status, patient)",Molecular,qPCR,ID,RNA,MTB 23S rRNA,NA,Fluorescence,Not applicable,NAT reagent kit (open source),NA,Standard lab instrumentation is required,Manual,Lab-based,Intended for professional use only,Sputum,NA,300,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbF7,Genechip MDR kit,CapitalBio Technology,China,Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://capitalbiotech.com/en/index.html,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,Other,ID-Prediction AST,DNA,Unknown,NA,Fluorescence,inhA; katG; rpoB,Cartridge-based processing,microarray chip based,A proprietary/new instrument is required,Unknown,Lab-based,Intended for professional use only,Sputum,NA,NA,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
a2r69000007lbEp,Mycobacterium Tuberculosis and Drug Resistance Gene Rapid NAT Test Kit,"Bao Ruiyuan Biotech(Beijing) Co.,ltd.",China,Western Pacific Region,Late Stage Development (fully functional prototype),Mycobacterium Tuberculosis,https://abiores.com,None,NA,Unknown,Diagnostic/confirmatory test,Molecular,qPCR,ID-Prediction AST,DNA,MTB H37Rv gene,NA,Fluorescence,embB; gyrA; gyrB; inhA; katG; rpoB; rpsL,Cartridge-based processing,NA,A proprietary/new instrument is required,Automated (excluding sample preparation),near Point of Care,Intended for professional use only,Sputum,NA,60,Yes,NA,NA,NA,Company-Sponsored,NA,NA,0,0,0,0,0,0,0,NA,0,0
